SANA logo

Sana Biotechnology (SANA) EBIT

Annual EBIT

-$293.14 M
-$20.58 M-7.55%

31 December 2023

SANA EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

-$61.76 M
-$12.39 M-25.09%

30 September 2024

SANA Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

-$312.48 M
-$59.58 M-23.56%

30 September 2024

SANA TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SANA EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-7.5%-2731.8%-9.9%
3 y3 years-2.4%+26.0%+12.9%
5 y5 years---

SANA EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-7.5%+17.9%-2731.8%+46.9%-50.3%+15.2%
5 y5 years-107.7%+17.9%-432.9%+65.8%-593.0%+27.9%
alltimeall time-107.7%+17.9%-432.9%+65.8%-593.0%+27.9%

Sana Biotechnology EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
-$61.76 M(+25.1%)
-$312.48 M(+23.6%)
June 2024
-
-$49.37 M(-55.4%)
-$252.90 M(-20.9%)
Mar 2024
-
-$110.72 M(+22.2%)
-$319.81 M(+9.1%)
Dec 2023
-$293.14 M(+7.5%)
-$90.62 M(+4054.9%)
-$293.14 M(+3.1%)
Sept 2023
-
-$2.18 M(-98.1%)
-$284.31 M(-22.8%)
June 2023
-
-$116.29 M(+38.4%)
-$368.32 M(+13.4%)
Mar 2023
-
-$84.05 M(+2.8%)
-$324.93 M(+19.2%)
Dec 2022
-$272.56 M
-$81.79 M(-5.1%)
-$272.56 M(-9.8%)
Sept 2022
-
-$86.19 M(+18.2%)
-$302.06 M(+0.9%)
June 2022
-
-$72.90 M(+130.1%)
-$299.30 M(+44.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$31.68 M(-71.5%)
-$207.84 M(-41.8%)
Dec 2021
-$356.91 M(+24.7%)
-$111.28 M(+33.4%)
-$356.91 M(-0.6%)
Sept 2021
-
-$83.43 M(-549.7%)
-$358.95 M(+9.7%)
June 2021
-
$18.55 M(-110.3%)
-$327.17 M(-24.6%)
Mar 2021
-
-$180.75 M(+59.5%)
-$433.63 M(+51.5%)
Dec 2020
-$286.15 M(+102.7%)
-$113.32 M(+119.4%)
-$286.15 M(+31.3%)
Sept 2020
-
-$51.64 M(-41.3%)
-$217.92 M(+31.1%)
June 2020
-
-$87.91 M(+164.2%)
-$166.27 M(+112.2%)
Mar 2020
-
-$33.27 M(-26.2%)
-$78.37 M(+73.8%)
Dec 2019
-$141.15 M
-$45.09 M
-$45.09 M

FAQ

  • What is Sana Biotechnology annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Sana Biotechnology?
  • What is Sana Biotechnology annual EBIT year-on-year change?
  • What is Sana Biotechnology quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Sana Biotechnology?
  • What is Sana Biotechnology quarterly EBIT year-on-year change?
  • What is Sana Biotechnology TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Sana Biotechnology?
  • What is Sana Biotechnology TTM EBIT year-on-year change?

What is Sana Biotechnology annual earnings before interest & taxes?

The current annual EBIT of SANA is -$293.14 M

What is the all time high annual EBIT for Sana Biotechnology?

Sana Biotechnology all-time high annual earnings before interest & taxes is -$139.33 M

What is Sana Biotechnology annual EBIT year-on-year change?

Over the past year, SANA annual earnings before interest & taxes has changed by -$20.58 M (-7.55%)

What is Sana Biotechnology quarterly earnings before interest & taxes?

The current quarterly EBIT of SANA is -$61.76 M

What is the all time high quarterly EBIT for Sana Biotechnology?

Sana Biotechnology all-time high quarterly earnings before interest & taxes is $18.55 M

What is Sana Biotechnology quarterly EBIT year-on-year change?

Over the past year, SANA quarterly earnings before interest & taxes has changed by -$59.58 M (-2731.77%)

What is Sana Biotechnology TTM earnings before interest & taxes?

The current TTM EBIT of SANA is -$312.48 M

What is the all time high TTM EBIT for Sana Biotechnology?

Sana Biotechnology all-time high TTM earnings before interest & taxes is -$45.09 M

What is Sana Biotechnology TTM EBIT year-on-year change?

Over the past year, SANA TTM earnings before interest & taxes has changed by -$28.17 M (-9.91%)